Comprehensive Behavioral Intervention for Tics
Launched by UNIVERSITY OF MIAMI · May 6, 2022
Trial Information
Current as of June 26, 2025
Recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a treatment called Comprehensive Behavioral Intervention for Tics (CBIT) for young people with tic disorders, such as Tourette's Syndrome or other similar conditions. The goal is to see how well this treatment works and to learn more about what factors might influence its success. The trial is currently recruiting participants aged 18 to 26 years and is open to all genders. To be eligible, individuals must have a diagnosed tic disorder or show signs of tic symptoms that cause significant difficulties in daily life. It's important that participants can speak and read English and have a parent or caregiver who can help with consent and questionnaires.
If you or someone you know is considering participating, you can expect to undergo assessments and complete surveys to help researchers understand the impact of the treatment. However, individuals with certain conditions, such as severe mental health issues or those currently receiving other forms of therapy, may not be eligible. The trial allows participants who are on specific psychiatric medications, as long as they do not require a break from their medication for the study. This research could provide valuable insights into effective ways to support young people dealing with tic disorders.
Gender
ALL
Eligibility criteria
- • Inclusion criteria
- • A current diagnosis of a Diagnostic and Statistical Manual of Mental Disorders (DSM)-5 Tic disorder (e.g., Tourette's Disorder/syndrome, Persistent (Chronic) Motor or Vocal Tic Disorder, or Provisional Tic Disorder) or caregiver/youth report of clinically impairing tic symptoms
- • Ability for youth to speak/read English sufficiently
- • At least one parent/caregiver available to sign study consent forms, remain present during assessments, and fill out study questionnaires in English.
- • Exclusion criteria
- • A current diagnosis of psychosis, bipolar disorder, intellectual disability, acute suicidality, alcohol/substance dependence, or eating disorder.
- • Youth currently receiving psychotherapy elsewhere and/or have previously received CBIT.
- • Currently suicidal or who have engaged in suicidal behaviors within the past 6 months will be excluded
- • Youth currently taking psychotropic medication for a co-morbid psychiatric illness will be included without a wash-out period (to not delay treatment).
About University Of Miami
The University of Miami, a leading academic institution, is dedicated to advancing medical research and improving patient care through innovative clinical trials. With a commitment to excellence in education and research, the university fosters collaboration among multidisciplinary teams to explore new therapies and treatment modalities. Its extensive clinical programs are supported by state-of-the-art facilities and a diverse patient population, enabling the exploration of cutting-edge solutions to complex health challenges. The University of Miami is poised to contribute significantly to the field of medicine through its rigorous scientific inquiry and a steadfast commitment to ethical research practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Coral Gables, Florida, United States
Patients applied
Trial Officials
Jill Ehrenreich-May, Ph.D.
Study Director
University of Miami
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials